Neuroscience
A press release from the FDA:
FDA approves first generic Lexapro to treat depression and anxiety disorder
14 March 2012
Read the full press release
- Fda Approves New Multiple Sclerosis Treatment: Tecfidera
FDA approves new multiple sclerosis treatment: Tecfidera 27 March 2013 Resd the press release ...
- Awake Mental Replay Of Past Experiences Critical For Learning
An NIH press release: Awake mental replay of past experiences critical for learning 07 May 2012 Read the release...
- "care Innovations"- A New Joint Ge-intel Project
An Intel press release on the 3rd of January: Read press release According the the press release, "Care Innovations will develop technologies that support healthy, independent living at home and in senior housing communities."...
- Fda: Lundbeck's Sabril (vigabatrin) And Infantile Spasms
From a press release by the FDA: Sabril Approved by FDA to Treat Spasms in Infants and Epileptic Seizures Sabril (vigabatrin) Oral Solution has been approved by the U.S. Food and Drug Administration to treat infantile spasms in children ages 1 month to...
- Fda Approves Invega (paliperidone)
An FDA Press Release: FOR IMMEDIATE RELEASE P06-208 December 20, 2006 Media Inquiries: Press Office, 301-827-6242 Consumer Inquiries: 888-INFO-FDA FDA Approves New Drug for Schizophrenia The Food and Drug Administration (FDA) today approved Invega (paliperidone)...
Neuroscience
FDA: Generic Lexapro
A press release from the FDA:
FDA approves first generic Lexapro to treat depression and anxiety disorder
14 March 2012
Read the full press release
- Fda Approves New Multiple Sclerosis Treatment: Tecfidera
FDA approves new multiple sclerosis treatment: Tecfidera 27 March 2013 Resd the press release ...
- Awake Mental Replay Of Past Experiences Critical For Learning
An NIH press release: Awake mental replay of past experiences critical for learning 07 May 2012 Read the release...
- "care Innovations"- A New Joint Ge-intel Project
An Intel press release on the 3rd of January: Read press release According the the press release, "Care Innovations will develop technologies that support healthy, independent living at home and in senior housing communities."...
- Fda: Lundbeck's Sabril (vigabatrin) And Infantile Spasms
From a press release by the FDA: Sabril Approved by FDA to Treat Spasms in Infants and Epileptic Seizures Sabril (vigabatrin) Oral Solution has been approved by the U.S. Food and Drug Administration to treat infantile spasms in children ages 1 month to...
- Fda Approves Invega (paliperidone)
An FDA Press Release: FOR IMMEDIATE RELEASE P06-208 December 20, 2006 Media Inquiries: Press Office, 301-827-6242 Consumer Inquiries: 888-INFO-FDA FDA Approves New Drug for Schizophrenia The Food and Drug Administration (FDA) today approved Invega (paliperidone)...